Quantcast
Higher BMI Found To Increase Risk Of Several Types Of Cancer

Higher BMI Found To Increase Risk Of Several Types Of Cancer

redOrbit Staff & Wire Reports - Your Universe Online Obesity increases a person’s risk of developing 10 of the most common forms of cancer, and is believed to cause an estimated 12,000 additional cases of the disease each year, experts...

Latest Prostate cancer Stories

2014-08-19 16:29:08

Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug. 19, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the $17.5 million convertible note offering announced last Thursday, August 14, 2014, has closed. The three-year notes have a 5% interest rate and are convertible at $7.30 per share of common stock. The...

2014-08-15 23:05:45

Ablative device manufacturer sponsors international focal therapy symposium, highlights HIFU sessions and invites international attendees to connect with key opinion leaders and company management. Charlotte, NC (PRWEB) August 15, 2014 SonaCare Medical, LLC, the global leader in urologic high intensity focused ultrasound (HIFU), is proud to provide platinum support for the upcoming 7th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer. This year’s...

2014-08-14 08:30:20

Company Strengthens Intellectual Property Protection in Additional Global Market DALLAS and NEW YORK, Aug. 14, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a patent for MuGard and ProctiGard has been granted. The patent covers a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders. "Following our recent European...

2014-08-13 23:01:47

North Texas Chapter of the Association of Clinical Research Professionals and Baylor Research Institute, join with Myriad Genetics, Lynch Syndrome International, Progeny and Ambry Genetics to bring global expert, Patrick Lynch, JD, MD, to Dallas to present lifesaving information on Lynch syndrome (HNPCC), a hereditary cancer condition, to bring a community outreach presentation, Saturday, August 16, 2014. Dallas, TX (PRWEB) August 13, 2014 The North Texas Chapter of the Association of...

2014-08-13 08:28:55

SYDNEY, Aug. 13, 2014 /PRNewswire/ -- Australia-US biotechnology company, Novogen Ltd. (ASX: NRT, NASDAQ: NVGN), an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia. A total of 28.3M shares were represented in person or by proxy at the meeting, during which the following resolutions were passed (95% in favor): RESOLUTION 1. SUBSEQUENT APPROVAL OF ISSUE OF...

2014-08-12 23:00:48

Leading Purveyor of Premium Tea Helps Further Prostate Cancer Research with Man Kind Tea NOVATO, CALIF. (PRWEB) August 12, 2014 The Republic of Tea, leading purveyor of premium teas, is thrilled to announce that it has surpassed the $500,000 donation mark to the Prostate Cancer Foundation (PCF) with sales from its Blueberry Green Superfruit™ Tea. The Republic of Tea currently donates $1 from the sale of each full-size tin and $0.36 from the sale of each traveler’s tin directly to PCF....

2014-08-12 20:22:06

LOS ANGELES, Aug. 12, 2014 /PRNewswire/ -- Online registration is open for a free community seminar on "Sexuality and Intimacy after Prostate Cancer." Hosted by the newly-created Skyline Urology Foundation, the seminar is offered to men with prostate cancer and/or their spouses or partners who may attend either as couples or as individuals. The seminar will take place on two dates in two Southern California locations: Saturday, Sept. 20, in the Manhattan Beach area and Saturday,...

2014-08-12 08:30:36

SYDNEY, Aug. 12, 2014 /PRNewswire/ -- The Australian biotechnology company, Novogen Limited (ASX: NRT; NASDAQ: NVGN), today announced receipt of funding from the FSHD Global Research Foundation as part of the Company's efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD). http://photos.prnewswire.com/prnvar/20131220/NY36990LOGO FSHD is one of the most common forms of muscular dystrophy and genetic hereditary...

2014-08-12 08:29:43

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets(http://www.researchandmarkets.com/research/cmxtrz/brachytherapy) has announced the addition of the "Brachytherapy - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Brachytherapy in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided...

2014-08-11 08:29:51

DALLAS, August 11, 2014 /PRNewswire/ -- The global digital pathology market is expected to grow at 11.8% CAGR to reach an estimated $437 million by 2018. In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related